Meeting
2016 Gastrointestinal Cancers Symposium
Next-generation sequencing (NGS) in an advanced hepatocellular carcinoma (HCC) cohort: Analyses of TP53 and CTNNB1.
Authors
Robin Kate Kelley
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Robin Kate Kelley , John Dozier Gordan , Kimberley Evason , Paige M. Bracci , Nancy M. Joseph , Andrea Grace Bocobo , Blake K. Rosenthal , Halla Sayed Nimeiri , Alan P. Venook
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 286)
DOI
10.1200/jco.2016.34.4_suppl.286
Abstract #
286
Poster Bd #
E10
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Detection of circulating tumor cells (CTC) using a non-EpCAM-based, high-definition, single-cell assay in advanced hepatocellular carcinoma (HCC) for patients enrolled on phase I and II trials of sorafenib plus temsirolimus.
First Author: Robin Kate Kelley
Poster
2014 ASCO Annual Meeting
A phase II study of temsirolimus in previously treated advanced hepatocellular carcinoma (HCC).
First Author: Jasgit C. Sachdev
Poster
2023 ASCO Annual Meeting
Molecular subtypes from comprehensive clustering from multi-omics dataset to predict the therapeutic efficacy of immunotherapeutic agent-based treatments in advanced hepatocellular carcinoma.
First Author: Hong Jae Chon
Poster
2022 ASCO Annual Meeting
Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC).
First Author: Darren Cowzer